Hi Dear, I want to run a de novo transcriptome project by Roche 454 with a species of fish cDNA library that its genome size is about 3*10^9, which kind of picotiter plate region is better for me and why? 1/2 or 1/4 or 1/8 ?
-
-
If the genome is 3E9 bp (similar to Homo sapiens)), then the transcriptome will be at least 3E6 bp. I'm not sure even 1/2 plate will have enough yield to cover your transcriptome, as there will be > 1000x difference between some transcript yields. You may need to use Illumina or Proton instead. -
I have run a devo transcriptome assembly using 454 on a fish with a similar sized genome (slightly larger than human genome). I ran 4 individuals in a whole 454 FLX run.
i used 3' targeted cDNA (however I seem to remember reading that for some reason this isnt the ideal protocol when using 454...?).
If memory serves I got around 30,000 contigs when aligning to a closely related reference transcriptome, and a bunch more via de novo assembly. From the 30, 000 contigs there were ~50K SNPs/indels identified....around 9K of these suited my criteria for a high quality putative SNP.
In theory 3' target cDNAs should increase yield of homologous fragments between individuals, and a full 454 plate seemed to give us good representation of the transcriptome.Last edited by JackieBadger; 10-07-2012, 11:43 AM.Comment
-
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...10-14-2026, 09:55 AM -
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...
Comment